Authors concluded, “The findings reported here emphasize the continued need for clear and consistent regulation from federal and state agencies to ensure label accuracy of CBD products.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“This is the first and largest population-based cross-sectional study of hospitalized patients to explore the association between cannabis use and HCC,” authors concluded.
“By failing to take up the case, SCOTUS … continues to evade the fundamental question with regard to cannabis’ medical validity.”
“The U.S. has a plethora of consumer protection laws. … So, it is understandable that Americans expect these same consumer protections in cannabis,” said the President & Founder of FOCUS.
Investigators concluded, “There is an urgent need to implement well-designed studies to evaluate the effectiveness and safety of medical marijuana for treating adults with migraines.”
“These data are consistent with other surveys showing that marijuana regulation policies can be implemented in a manner that provides access for adults while simultaneously limiting youth access and misuse.”
Investigators concluded, “Medical cannabis treatment … demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects.”
Researchers reported, “Topical CBD treatment demonstrated significant improvements in … arthritis-related pain and disability without adverse events.”